Manufacturer record
SGS Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by SGS Pharmaceuticals Pvt. Ltd (Uttarakhand) was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SGALD26004, Diclofenac Sodium Injection I.P. (exp Jan 2028). ALIGARH, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conforms to I.P. in the respect of content of diclofenac sodium. Listed in the September 2026 alert.
Records by type
1 record linked to SGS Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Injection I.P. | Batch SGALD26004Mfg Feb 2026 · Exp Jan 2028 | The sample does not conforms to I.P. in the respect of content of diclofenac sodium.Other | ALIGARH, Uttar PradeshState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.